154 related articles for article (PubMed ID: 27423551)
1. Genetic polymorphisms in 5-Fluorouracil-related enzymes predict pathologic response after neoadjuvant chemoradiation for rectal cancer.
Nelson B; Carter JV; Eichenberger MR; Netz U; Galandiuk S
Surgery; 2016 Nov; 160(5):1326-1332. PubMed ID: 27423551
[TBL] [Abstract][Full Text] [Related]
2. Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer.
Hur H; Kang J; Kim NK; Min BS; Lee KY; Shin SJ; Keum KC; Choi J; Kim H; Choi SH; Lee MY
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):669-76. PubMed ID: 20932673
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer.
Villafranca E; Okruzhnov Y; Dominguez MA; García-Foncillas J; Azinovic I; Martínez E; Illarramendi JJ; Arias F; Martínez Monge R; Salgado E; Angeletti S; Brugarolas A
J Clin Oncol; 2001 Mar; 19(6):1779-86. PubMed ID: 11251009
[TBL] [Abstract][Full Text] [Related]
4. X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients.
Lamas MJ; Duran G; Gomez A; Balboa E; Anido U; Bernardez B; Rana-Diez P; Lopez R; Carracedo A; Barros F
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):138-44. PubMed ID: 21167658
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.
Balboa E; Duran G; Lamas MJ; Gomez-Caamaño A; Celeiro-Muñoz C; Lopez R; Carracedo A; Barros F
Pharmacogenomics; 2010 Jun; 11(6):747-61. PubMed ID: 20504250
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of thymidylate synthase polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Arrazubi V; Suárez J; Guerrero D; Gómez M; Viúdez A; Arias F; Balén E; Vera R
Colorectal Dis; 2013 Apr; 15(4):428-35. PubMed ID: 22958523
[TBL] [Abstract][Full Text] [Related]
7. Association of thymidylate synthase polymorphisms with the tumor response to preoperative chemoradiotherapy in rectal cancer: a systematic review and meta-analysis.
Yang YC; Wu GC; Jin L; Wang KL; Bai ZG; Wang J; Zhang ZT
Pharmacogenomics J; 2017 Jun; 17(3):265-273. PubMed ID: 27001118
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes.
Páez D; Salazar J; Paré L; Pertriz L; Targarona E; del Rio E; Barnadas A; Marcuello E; Baiget M
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1319-27. PubMed ID: 21570215
[TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil.
Páez D; Paré L; Altés A; Sancho-Poch FJ; Petriz L; Garriga J; Monill JM; Salazar J; del Rio E; Barnadas A; Marcuello E; Baiget M
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1681-9. PubMed ID: 20165956
[TBL] [Abstract][Full Text] [Related]
10. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
11. Role of genetic polymorphisms in NFKB-mediated inflammatory pathways in response to primary chemoradiation therapy for rectal cancer.
Dzhugashvili M; Luengo-Gil G; García T; González-Conejero R; Conesa-Zamora P; Escolar PP; Calvo F; Vicente V; Ayala de la Peña F
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):595-602. PubMed ID: 25304949
[TBL] [Abstract][Full Text] [Related]
12. [Thymidylate synthase gene promoter polymorphism in patients with advanced head and neck cancer treated by radio- and 5-fluorouracil chemotherapy].
Kiss-László Z; Nagy B; Thurzó L; Szabó J
Magy Onkol; 2006; 50(1):33-7. PubMed ID: 16617381
[TBL] [Abstract][Full Text] [Related]
13. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
[TBL] [Abstract][Full Text] [Related]
14. Thymidylate synthase genotypes and tumour regression in stage II/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiation.
Stoehlmacher J; Goekkurt E; Mogck U; Aust DE; Kramer M; Baretton GB; Liersch T; Ehninger G; Jakob C
Cancer Lett; 2008 Dec; 272(2):221-5. PubMed ID: 18722050
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review of Candidate Single-nucleotide Polymorphisms as Biomarkers for Responsiveness to Neoadjuvant Chemoradiation for Rectal Cancer.
Maring ED; Tawadros PS; Steer CJ; Lee JT
Anticancer Res; 2015 Jul; 35(7):3761-6. PubMed ID: 26124319
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer.
Moureau-Zabotto L; Farnault B; de Chaisemartin C; Esterni B; Lelong B; Viret F; Giovannini M; Monges G; Delpero JR; Bories E; Turrini O; Viens P; Salem N
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):483-91. PubMed ID: 21093174
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy.
Jakob C; Liersch T; Meyer W; Baretton GB; Schwabe W; Häusler P; Kulle B; Becker H; Aust DE
Am J Surg Pathol; 2006 Sep; 30(9):1169-74. PubMed ID: 16931962
[TBL] [Abstract][Full Text] [Related]
18. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene.
Kawakami K; Watanabe G
Cancer Res; 2003 Sep; 63(18):6004-7. PubMed ID: 14522928
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment expression of 13 molecular markers as a predictor of tumor responses after neoadjuvant chemoradiation in rectal cancer.
Huh JW; Lee JH; Kim HR
Ann Surg; 2014 Mar; 259(3):508-15. PubMed ID: 23787217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
